Abstract
AIMSElectronic healthcare records (EHRs) are increasingly used to store clinical information. A secondary benefit of EHRs is their use, in an anonymized form, for observational research. The Clinical Practice Research Datalink (CPRD) contains EHRs from primary care in the UK and, despite 1083 peer-reviewed research publications, has never been used to obtain pharmacogenetic samples. Using a statin-induced myopathy paradigm, we evaluated using the CPRD to obtain patient samples for a pharmacogenetic study targeting 250 cases and 500 controls from UK general practitioner (GP) practices.METHODSThe CPRD identified potential patients fitting specific case-definition criteria (active rhabdomyolysis or creatine phosphokinase > four times the upper limit of normal), and corresponding GP practices were asked to invite patient participation. Consenting patients were requested to provide either saliva or blood samples and to complete an ethnicity questionnaire. Control subjects were recruited from the same GP practice (saliva) or a small number of practices (blood). Samples were forwarded for DNA extraction.RESULTSThirty-six months of recruitment yielded DNA samples from 149 statin-induced myopathy cases and 587 tolerant controls. Data show that contacting patients through their GP is a reliable method for obtaining samples without compromising anonymity. Saliva collection directly from patients was considerably less effective than blood sampling. After 10 months of recruitment, saliva sampling was suspended in favour of blood sampling.CONCLUSIONSWe demonstrate the potential of EHRs for identifying accurately phenotyped cases and controls for pharmacogenetic studies. Recruitment was successful only because of the willingness of GP practices to participate and the existence of strong doctor–patient relationships. The present study provides a model that can be implemented in future genetic analyses using EHRs.
Highlights
Healthcare systems are increasingly using computers to record and store clinical information
The importance of electronic health record databases for conducting research has been widely acknowledged; to date, they have mainly been used for epidemiological research
A case in point is the Clinical Practice Research Datalink (CPRD), which has resulted in 1083 peer-reviewed publications
Summary
Healthcare systems are increasingly using computers to record and store clinical information. The CPRD has evolved over time, with increasing population coverage and, through linkages with secondary care data and laboratory data, provides access to more complete data sets. This makes it a highly valuable resource that is widely used by academic, regulatory and industry sectors. The CPRD has been widely used for observational research, the data have not been linked to biological samples, such as DNA. The UK biobank, in contrast, currently has access to biological samples and will eventually have access to linked health records. The CPRD is much larger than the UK biobank and would be valuable to improve our understanding of the genetic basis of rarer phenotypes, if these could be linked to biological samples. One area of medical research that would greatly benefit from this is the pharmacogenetics of adverse drug reactions
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have